Advertisement
Journal Home
Search for

248 Periodical Search Results

You searched for "ara-c" within Leukemia Research

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-20  of 248 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7  >

display abstract citation download email a colleague
Display:

  1. Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot study
    T Kühr, W Eisterer, U Apfelbeck, W Linkesch, O Bechter, A Zabernigg, K Geissler, G Barbieri, C Duba, G Gastl, J Thaler
    Leukemia Research
    July 2000 (Vol. 24, Issue 7, Pages 583-587)
    Abstract | Full Text | Full-Text PDF (87 KB)

  1. Influence of rhGM-CSF on Ara-C sensitivity of patients with acute myeloid leukemia in relapse: A flow cytometry study
    Francis Lacombe, Maryse Puntous, Patrice Dumain, Pascale Cony-Makhoul, Francis Belloc, Philippe Bernard, Michel Boisseau, Josy Reiffers
    Leukemia Research
    June 1996 (Vol. 20, Issue 6, Pages 481-489)
    Abstract | Abstract + References | Full-Text PDF (823 KB)

  1. Effects of fludarabine and gemcitabine on human acute myeloid leukemia cell line HL 60: Direct comparison of cytotoxicity and cellular Ara-C uptake enhancement
    Valeria Santini, Gianluca D'Ippolito, Pietro Antonio Bernabei, Antonella Zoccolante, Angela Ermini, Pierluigi Rossi-Ferrini
    Leukemia Research
    January 1996 (Vol. 20, Issue 1, Pages 37-45)
    Abstract | Abstract + References | Full-Text PDF (1026 KB)

  1. A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia
    Peter J. Rosen, Cathryn Rankin, David R. Head, David H. Boldt, Frederick W. Luthardt, Thomas Norwood, Reginald P. Pugh, Chatchada Karanes, Frederick R. Appelbaum
    Leukemia Research
    March 2000 (Vol. 24, Issue 3, Pages 183-187)
    Abstract | Full Text | Full-Text PDF (65 KB)

  1. Commentary: dose intensive chemotherapy in acute myeloid leukemia
    Eric J. Feldman
    Leukemia Research
    March 2001 (Vol. 25, Issue 3, Pages 217-219)
    Full Text | Full-Text PDF (45 KB)

  1. A fludarabine, topotecan, and cytarabine regimen is active in patients with refractory acute myelogenous leukemia
    Francis J Giles, Jorge E Cortes, Hagop M Kantarjian, Susan M O’Brien, Elihu Estey, Miloslav Beran
    Leukemia Research
    April 2004 (Vol. 28, Issue 4, Pages 353-357)
    Abstract | Full Text | Full-Text PDF (66 KB)

  1. Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-l-aspartate in human leukemic blast cells and cell lines
    Paul Noordhuis, Karin M. Kazemier, Gert-Jan L. Kaspers, Godefridus J. Peters
    Leukemia Research
    February 1996 (Vol. 20, Issue 2, Pages 127-134)
    Abstract | Abstract + References | Full-Text PDF (782 KB)

  1. Intensive therapy for high-risk myelodysplastic syndromes and the biological significance of karyotype abnormalities
    W Hiddemann, G Jahns-Streubel, W Verbeek, B Wörmann, D Haase, C Schoch
    Leukemia Research
    1 May 1998 (Vol. 22Supplement 1, Pages S23-S26)
    Abstract | Full Text | Full-Text PDF (52 KB)

  1. In vitro leukemia cell models of Ara-C resistance
    Tadao Funato, Junko Satou, Yuko Nishiyama, Shinichi Fujimaki, Toshihiko Miura, Mitsuo Kaku, Takeshi Sasaki
    Leukemia Research
    June 2000 (Vol. 24, Issue 6, Pages 535-541)
    Abstract | Full Text | Full-Text PDF (202 KB)

  1. What does over-expression of cN-II enzyme signify in haematological malignancies?
    Carlos M. Galmarini
    Leukemia Research
    October 2007 (Vol. 31, Issue 10, Pages 1325-1326)
    Full Text | Full-Text PDF (86 KB)

  1. Interferon-α for the treatment of elderly patients with chronic myeloid leukaemia
    Wolfgang Hilbe, Ute Apfelbeck, Michael Fridrik, Marianne Bernhart, Herwig Niessner, Klaus Abbrederis, Gerhard Michlmayr, Jörg Pont, Werner Linkesch, Hubert Hausmaninger, Klaus Arneitz, Christian Baldinger, Christoph Duba, Wolfgang Eisterer, Richard Greil, Günther Konwalinka, Dietger Niederwieser, Günther Gastl, Josef Thaler
    Leukemia Research
    1 October 1998 (Vol. 22, Issue 10, Pages 881-886)
    Abstract | Full Text | Full-Text PDF (79 KB)

  1. Sodium butyrate enhances the cytotoxic effect of antineoplastic drugs in human lymphoblastic T-cells
    M.P. dos Santos, G. Schwartsmann, R. Roesler, A.L. Brunetto, A.L. Abujamra
    Leukemia Research
    February 2009 (Vol. 33, Issue 2, Pages 218-221)
    Abstract | Full Text | Full-Text PDF (260 KB)

  1. Modulation of resistance to ara-C by bryostatin in fresh blast cells from patients with AML
    Alena W Elgie, Jean M Sargent, Peter Alton, Godefridus J Peters, Paul Noordhuis, Christine J Williamson, Colin G Taylor
    Leukemia Research
    April 1998 (Vol. 22, Issue 4, Pages 373-378)
    Abstract | Abstract + References | Full-Text PDF (606 KB)

  1. Augmentation by aphidicolin of 1-β-d-arabinofuranosylcytosine-induced c-jun and NF-κB activation in a human myeloid leukemia cell line: Correlation with apoptosis
    Katsuji Kuwakado, Masaru Kubota, Rikimaru Bessho, Akihiro Kataoka, Ikuya Usami, Ying Wei Lin, Akiro Okuda, Yoshihiro Wakazono
    Leukemia Research
    September 1995 (Vol. 19, Issue 9, Pages 645-650)
    Abstract | Abstract + References | Full-Text PDF (1633 KB)

  1. Effect of stem cell factor on leukemic progenitor cell growth and sensitivity to cytosine-arabinoside
    Jean-François Viallard, Christophe Grosset, Francis Lacombe, Selva David, François-Xavier Mahon, Caroline Barbot, Isabelle Vianes, Maryse Dupouy, Josy Reiffers
    Leukemia Research
    November 1996 (Vol. 20, Issue 11, Pages 915-923)
    Abstract | Abstract + References | Full-Text PDF (941 KB)

  1. Novel regimen for the treatment of juvenile myelomonocytic leukemia (JMML)
    Hyoung Jin Kang, Hee Young Shin, Hyoung Soo Choi, Hyo Seop Ahn
    Leukemia Research
    February 2004 (Vol. 28, Issue 2, Pages 167-170)
    Abstract | Full Text | Full-Text PDF (49 KB)

  1. Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years
    Anna Candoni, Giovanni Martinelli, Eleonora Toffoletti, Alexia Chiarvesio, Mario Tiribelli, Michele Malagola, Pier Paolo Piccaluga, Angela Michelutti, Erica Simeone, Daniela Damiani, Domenico Russo, Renato Fanin
    Leukemia Research
    December 2008 (Vol. 32, Issue 12, Pages 1800-1808)
    Abstract | Full Text | Full-Text PDF (307 KB)

  1. Bone marrow stromal cells regulate caspase 3 activity in leukemic cells during chemotherapy
    James E Fortney, Wei Zhao, Sharon L Wenger, Laura F Gibson
    Leukemia Research
    October 2001 (Vol. 25, Issue 10, Pages 901-907)
    Abstract | Full Text | Full-Text PDF (422 KB)

  1. JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C)
    Paul J. Shami, Anna E. Maciag, Jordan K. Eddington, Vidya Udupi, Ken M. Kosak, Joseph E. Saavedra, Larry K. Keefer
    Leukemia Research
    November 2009 (Vol. 33, Issue 11, Pages 1525-1529)
    Abstract | Full Text | Full-Text PDF (385 KB)

  1. In vitro chemosensitivity testing in acute non lymphocytic leukemia using the bioluminescence ATP assay
    Lars Möllgård, Ulf Tidefelt, Britt Sundman-Engberg, Christina Löfgren, Christer Paul
    Leukemia Research
    May 2000 (Vol. 24, Issue 5, Pages 445-452)
    Abstract | Full Text | Full-Text PDF (189 KB)
display abstract citation download email a colleague
Display:

  Viewing 1-20  of 248 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7  >

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement